121 related articles for article (PubMed ID: 10178697)
1. Immunoadsorption--a new therapeutic possibility for multiple sclerosis?
Schneidewind JM; Winkler R; Ramlow W; Tiess M; Hertel U; Sehland D
Transfus Sci; 1998 Mar; 19 Suppl():59-63. PubMed ID: 10178697
[TBL] [Abstract][Full Text] [Related]
2. Successful immunoadsorption with membrane plasmapheresis for multiple sclerosis.
Hosokawa S; Oyamaguchi A; Yoshida O
ASAIO Trans; 1989; 35(3):576-7. PubMed ID: 2688722
[TBL] [Abstract][Full Text] [Related]
3. Immunoadsorption patients with multiple sclerosis: an open-label pilot study.
Moldenhauer A; Haas J; Wäscher C; Derfuss T; Hoffmann KT; Kiesewetter H; Salama A
Eur J Clin Invest; 2005 Aug; 35(8):523-30. PubMed ID: 16101673
[TBL] [Abstract][Full Text] [Related]
4. [Immunoadsorption for steroid-unresponsive multiple sclerosis-relapses: clinical data of 14 patients].
Mauch E; Zwanzger J; Hettich R; Fassbender C; Klingel R; Heigl F
Nervenarzt; 2011 Dec; 82(12):1590-5. PubMed ID: 21667161
[TBL] [Abstract][Full Text] [Related]
5. Is there a rationale for therapeutic immunoadsorption in multiple sclerosis?
Berger T
Eur J Clin Invest; 2005 Aug; 35(8):467-8. PubMed ID: 16101665
[No Abstract] [Full Text] [Related]
6. [Tryptophan immunoadsorption for multiple sclerosis and neuromyelitis optica: therapy option for acute relapses during pregnancy and breastfeeding].
Hoffmann F; Kraft A; Heigl F; Mauch E; Koehler J; Harms L; Kümpfel T; Köhler W; Klingel R; Fassbender C; Schimrigk S
Nervenarzt; 2015 Feb; 86(2):179-86. PubMed ID: 25604838
[TBL] [Abstract][Full Text] [Related]
7. Mitoxantrone: a review of its use in multiple sclerosis.
Scott LJ; Figgitt DP
CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
[TBL] [Abstract][Full Text] [Related]
8. [The use of therapeutic apheresis in neurological diseases and comparison between plasma exchange and immunoadsorption].
Loschiavo C; Grecò M; Polo A; Del Colle R
G Ital Nefrol; 2015; 32(1):. PubMed ID: 25774587
[TBL] [Abstract][Full Text] [Related]
9. Immunoadsorption (IA) versus plasma exchange (PE) in multiple sclerosis--first results of a double blind controlled trial.
Schmitt E; Behm E; Buddenhagen F; Ernst B; Hitzschke B; Kracht M; Korten G; Kundt G; Meyer-Rienecker H; Osten B
Prog Clin Biol Res; 1990; 337():289-92. PubMed ID: 2191322
[No Abstract] [Full Text] [Related]
10. Plasma exchange in chronic progressive multiple sclerosis: a long-term study.
Khatri BO; McQuillen MP; Hoffmann RG; Harrington GJ; Schmoll D
Neurology; 1991 Mar; 41(3):409-14. PubMed ID: 2006010
[TBL] [Abstract][Full Text] [Related]
11. Immunoadsorption in steroid-refractory multiple sclerosis: clinical experience in 60 patients.
Heigl F; Hettich R; Arendt R; Durner J; Koehler J; Mauch E
Atheroscler Suppl; 2013 Jan; 14(1):167-73. PubMed ID: 23357160
[TBL] [Abstract][Full Text] [Related]
12. Differences in the Reponses to Apheresis Therapy of Patients With 3 Histopathologically Classified Immunopathological Patterns of Multiple Sclerosis.
Stork L; Ellenberger D; Beißbarth T; Friede T; Lucchinetti CF; Brück W; Metz I
JAMA Neurol; 2018 Apr; 75(4):428-435. PubMed ID: 29404583
[TBL] [Abstract][Full Text] [Related]
13. [Rapid modification of the symptomatology of progressive forms of multiple sclerosis by plasma exchange].
Trouillas P; Neuschwander P; Trémisi JP
Rev Neurol (Paris); 1986; 142(8-9):689-95. PubMed ID: 3809855
[TBL] [Abstract][Full Text] [Related]
14. Immunoadsorption and plasma exchange in multiple sclerosis: complement and plasma protein behaviour.
Palm M; Behm E; Schmitt E; Buddenhagen F; Hitzschke B; Kracht M; Kundt G; Meyer-Rienecker H; Klinkmann H
Biomater Artif Cells Immobilization Biotechnol; 1991; 19(1):283-96. PubMed ID: 1751678
[TBL] [Abstract][Full Text] [Related]
15. Treatment of multiple sclerosis with hyperbaric oxygen. Results of a national registry.
Kindwall EP; McQuillen MP; Khatri BO; Gruchow HW; Kindwall ML
Arch Neurol; 1991 Feb; 48(2):195-9. PubMed ID: 1993011
[TBL] [Abstract][Full Text] [Related]
16. Immunoadsorption in neurological disorders.
Oji S; Nomura K
Transfus Apher Sci; 2017 Oct; 56(5):671-676. PubMed ID: 28919008
[TBL] [Abstract][Full Text] [Related]
17. Fibrinogen reduction and bleeding complications in plasma exchange, immunoadsorption and a combination of the two.
Zöllner S; Pablik E; Druml W; Derfler K; Rees A; Biesenbach P
Blood Purif; 2014; 38(2):160-6. PubMed ID: 25501972
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic plasma exchange combined with immunomodulating agents in secondary progressive multiple sclerosis patients.
Grapsa E; Triantafyllou N; Rombos A; Lagouranis A; Dimopoulos MA
Ther Apher Dial; 2008 Apr; 12(2):105-8. PubMed ID: 18387157
[TBL] [Abstract][Full Text] [Related]
19. Open controlled therapeutic trial of intravenous immune globulin in relapsing-remitting multiple sclerosis.
Achiron A; Pras E; Gilad R; Ziv I; Mandel M; Gordon CR; Noy S; Sarova-Pinhas I; Melamed E
Arch Neurol; 1992 Dec; 49(12):1233-6. PubMed ID: 1449400
[TBL] [Abstract][Full Text] [Related]
20. Treatment of progressive multifocal leukoencephalopathy associated with natalizumab.
Wenning W; Haghikia A; Laubenberger J; Clifford DB; Behrens PF; Chan A; Gold R
N Engl J Med; 2009 Sep; 361(11):1075-80. PubMed ID: 19741228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
